Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityNo recent work listed

Faiz Gani

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0371-1943; OpenAlex author ID A5086040195. Sources: OpenAlex.

Their work

Papers
5 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: 2 papers · 2018: 1 paper

Papers 5

  1. Assessing the Financial Burden Associated With Treatment Options for Resectable Pancreatic Cancer. First author DOI 10.1097/sla.0000000000002069↗
  2. Impact of Angiotensin Receptor Blocker Use on Overall Survival Among Patients Undergoing Resection for Pancreatic Cancer. First author DOI 10.1007/s00268-017-4021-8↗
  3. Hospital Volume and the Costs Associated with Surgery for Pancreatic Cancer. Co-author DOI 10.1007/s11605-017-3479-x↗
  4. Metformin Use Is Associated with Improved Survival in Patients Undergoing Resection for Pancreatic Cancer. First author DOI 10.1007/s11605-016-3173-4↗
  5. Perioperative Blood Transfusion and the Prognosis of Pancreatic Cancer Surgery: Systematic Review and Meta-analysis. Co-author DOI 10.1245/s10434-015-4823-6↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Timothy Michael Pawlik · 5 shared papers, 2015–2018 · strength 0.38
  2. Marcelo Cerullo · 4 shared papers, 2016–2018 · strength 0.33
  3. Sophia Y. Chen · 3 shared papers, 2016–2018 · strength 0.26
  4. Joseph M. Herman · 1 shared paper, 2018 · strength 0.09
  5. Daniel A. Laheru · 1 shared paper, 2018 · strength 0.09
  6. Fabian Mc. Johnston · 1 shared paper, 2017 · strength 0.08
  7. Mary E. Dillhoff · 1 shared paper, 2017 · strength 0.08
  8. Gaya Spolverato · 1 shared paper, 2015 · strength 0.05
  9. Michail N. Mavros · 1 shared paper, 2015 · strength 0.05
  10. Aslam M. Ejaz · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.